How to Help Your Patients Save Money on Milnacipran (Savella): A Provider's Guide to Savings Programs

Milnacipran (Savella) is an effective fibromyalgia treatment for many patients — but at a cash price exceeding $500 for a 30-day supply of brand Savella, cost is a real barrier to adherence. For prescribers, proactively addressing cost at the point of prescribing can be the difference between a patient who stays on therapy and one who abandons it at the pharmacy counter.

This guide gives you a practical overview of the savings resources available for Milnacipran patients — including who qualifies for each, how to enroll, and how to integrate these conversations into your clinical workflow.

Understanding the Cost Landscape for Milnacipran

The cost challenge for your fibromyalgia patients comes from several angles:

High brand-name cash price: Brand Savella retails at $466–$766 for 60 tablets (50 mg), a 30-day supply. Few patients can sustain this out-of-pocket.

Formulary tier barriers: Most commercial plans place Milnacipran at Tier 3-4, with prior authorization requirements and often step therapy mandates.

Inconsistent generic availability: Generic milnacipran is FDA-approved and less expensive, but not always available at retail pharmacies, limiting this lower-cost option for some patients.

Medicare exclusion: The manufacturer savings card excludes Medicare and Medicaid patients, who may face the highest barriers.

Resource 1: The Savella Manufacturer Savings Card

The most powerful savings tool for commercially insured patients is the Savella Savings Card from AbbVie/Allergan (available at savella.com):

Savings: As little as $20 per 30-day, 60-day, or 90-day supply

Fill limit: 12 fills (30-day), 6 fills (60-day), or 4 fills (90-day)

Eligibility: Commercially insured patients 18+; NOT valid for Medicare, Medicaid, TRICARE, or other federal/state programs

How to access: Direct patients to savella.com, or keep printed copies in your office to distribute at the point of prescribing

A 90-day fill at $20 works out to approximately $0.22/day — a dramatic reduction from the $8+/day cash price. Recommend 90-day prescriptions for stable patients to maximize this value.

Resource 2: Pharmacy Discount Programs (GoodRx and SingleCare)

For patients ineligible for the manufacturer card (Medicare beneficiaries, uninsured patients, or those whose insurance copay exceeds available discounts), pharmacy discount programs can provide meaningful savings:

SingleCare: Published price of approximately $38.93 for 60 tablets (50 mg) at participating pharmacies — representing an 80%+ reduction from cash price

GoodRx: Variable pricing by location; compare at goodrx.com for local pharmacy prices

Remind patients that these coupons cannot be combined with insurance and that the manufacturer savings card cannot be combined with GoodRx/SingleCare — they should use whichever gives the best price at their specific pharmacy.

Resource 3: Patient Assistance Programs for Uninsured and Underinsured Patients

For patients who truly cannot afford Milnacipran even with discounts, patient assistance programs (PAPs) may provide free or heavily subsidized medication. Key resources:

AbbVie myAbbVie Assist: AbbVie's patient assistance program for uninsured or underinsured patients. Visit myabbvieassist.com or call 1-800-222-6885.

NeedyMeds.org: Nonprofit database of PAPs by drug name. Free eligibility screening and application resources. Consider giving patients this URL.

RxAssist.org: Another free PAP directory. Particularly useful for patients who need help navigating multiple applications.

Your practice's social worker or case manager: If your practice has one, refer patients to them for PAP enrollment assistance — the paperwork can be complex.

Formulary Navigation: Getting Milnacipran Covered by Insurance

When prior authorization (PA) is required, your office staff can streamline the process by:

Documenting step therapy. Most payers require documented trial and failure of first-line agents (duloxetine, pregabalin, gabapentin, tricyclics, cyclobenzaprine). Include specific dates, doses, duration, and reasons for failure or intolerance.

Writing a clinical justification. Include clinical rationale for Milnacipran specifically — e.g., norepinephrine preference for fatigue-predominant fibromyalgia, minimal CYP450 interactions important in polypharmacy patients, patient's specific failed alternatives.

Submitting a peer-to-peer review request. For denied PAs, request a peer-to-peer review where you can speak directly with the payer's medical reviewer. These reviews significantly improve approval rates when requested promptly.

Using the Savella Savings Card as a bridge. For commercially insured patients awaiting PA approval, the Savella Savings Card can cover initial fills while the authorization process plays out.

Prescribing 90-Day Supplies: A Simple Step with Big Impact

When writing Milnacipran prescriptions for stable patients, routinely prescribe 90-day supplies with refills where formulary permits. This reduces cost through:

Lower per-dose cost at mail-order (typically 33% savings vs. 30-day retail)

Maximizing Savella Savings Card value (as little as $20 for 90-day supply vs. $20 for a 30-day fill)

Reduced pharmacy trips and improved adherence

When Generic Milnacipran Is the Right Cost Choice

Generic milnacipran is bioequivalent to brand Savella and generally less expensive. However, availability at retail pharmacies has been inconsistent. When writing prescriptions:

Indicate "Substitution Permitted" (or do not write DAW) to allow the pharmacist to dispense whichever form is available and most cost-effective

Note that generic milnacipran may not be stocked at all pharmacies; patients may need to search or order in advance

Direct patients to medfinder to find pharmacies in their area that currently have the generic in stock

Having the Cost Conversation at the Point of Prescribing

Research consistently shows that patients who are surprised by cost at the pharmacy are more likely to abandon prescriptions than those who received cost information and savings resources from their provider. A 30-second proactive cost conversation at the point of prescribing can dramatically improve adherence:

Suggested script: "Savella can be expensive if you're paying cash, but if you have commercial insurance, this savings card can bring it down to $20 or less per month. If you run into any issues at the pharmacy — either with cost or finding it in stock — call us and we'll help you troubleshoot. There are also some great alternatives if cost is still a barrier."

For more on supporting your Milnacipran patients beyond cost, see our guide on helping patients find Milnacipran in stock. To learn more about how medfinder supports your patients when they can't locate their medication, visit medfinder.com/providers.